Kearney Terrence C 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Aug 14, 2023
Insider Transaction Report
Form 4
Kearney Terrence C
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-10$127.54/sh+10,000$1,275,400→ 16,536 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-08-10−10,000→ 10,000 totalExercise: $127.54Exp: 2025-05-31→ Common Stock (10,000 underlying) - Sale
Common Stock
2023-08-10$350.00/sh−10,000$3,500,000→ 6,536 total
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.
- [F2]Fully vested.